California Water Service Group schedules third-quarter earnings release, conference call
Bitget2026/10/08 20:15California Water Service Group will release 2026 third-quarter earnings results before 9:00 a.m. ET on Oct. 29, 2026. An earnings conference call is scheduled for 11:00 a.m. ET on Oct. 29, 2026, with a live webcast at https://edge.media-server.com/mmc/p/5ckhdfck. A replay will run from 2:00 p.m. ET on Oct. 29, 2026, through Nov. 28, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. California Water Service Group published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610081615PRIMZONEFULLFEED9841018) on October 08, 2026, and is solely responsible for the information contained therein.
- California Water Service Group will release 2026 third-quarter earnings results before 9:00 a.m. ET on Oct. 29, 2026.
- An earnings conference call is scheduled for 11:00 a.m. ET on Oct. 29, 2026, with a live webcast at https://edge.media-server.com/mmc/p/5ckhdfck.
- A replay will run from 2:00 p.m. ET on Oct. 29, 2026, through Nov. 28, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
3D printing materials supplier Amaero (AMRO.US) restarts US IPO, fundraising drops 60% to $20 million
Amaero (AMRO.US) on Thursday resumed its initial public offering (IPO) plans in the United States and filed new documents with the U.S. Securities and Exchange Commission (SEC), revealing a reduced number of shares to be issued.
Even with Eli Lilly's endorsement, TRex Bio (TRXB.US) struggles to enjoy a premium, as the issue price drops to the lower limit of $14.
Early-stage biotechnology company TRex Bio has priced its IPO at the lower end of the range at $14 per share, raising $116.7 million and achieving a market capitalization of $384 million. The company will be listed on Nasdaq on Friday, with Eli Lilly expressing interest in increasing its stake.
Small molecule biotechnology company Iambic Therapeutics (IAM.US) IPO priced at $15-17 per share, aiming to raise $150 millions.
Iambic Therapeutics plans to raise $150 millions by issuing 9.4 million shares, with an offering price range of $15 to $17 per share.
Crypto prices
More
